| Prediction of cancer outcome with microarrays: a multiple random validation strategy S Michiels, S Koscielny, C Hill The Lancet 365 (9458), 488-492, 2005 | 1255 | 2005 |
| Hyperprogressive disease in patients with advanced non–small cell lung cancer treated with PD-1/PD-L1 inhibitors or with single-agent chemotherapy R Ferrara, L Mezquita, M Texier, J Lahmar, C Audigier-Valette, ... JAMA oncology 4 (11), 1543-1552, 2018 | 683 | 2018 |
| False discovery rate, sensitivity and sample size for microarray studies Y Pawitan, S Michiels, S Koscielny, A Gusnanto, A Ploner Bioinformatics 21 (13), 3017-3024, 2005 | 578 | 2005 |
| Breast cancer: relationship between the size of the primary tumour and the probability of metastatic dissemination S Koscielny, M Tubiana, MG Le, AJ Valleron, H Mouriesse, G Contesso, ... British journal of cancer 49 (6), 709-715, 1984 | 517 | 1984 |
| Full-dose reirradiation for unresectable head and neck carcinoma: experience at the Gustave-Roussy Institute in a series of 169 patients. R De Crevoisier, J Bourhis, C Domenge, P Wibault, S Koscielny, ... Journal of Clinical Oncology 16 (11), 3556-3562, 1998 | 356 | 1998 |
| Comparison of seven serum thyroglobulin assays in the follow-up of papillary and follicular thyroid cancer patients M Schlumberger, A Hitzel, ME Toubert, C Corone, F Troalen, ... The Journal of Clinical Endocrinology & Metabolism 92 (7), 2487-2495, 2007 | 267 | 2007 |
| A 16-gene assay to predict recurrence after surgery in localised renal cell carcinoma: development and validation studies B Rini, A Goddard, D Knezevic, T Maddala, M Zhou, H Aydin, S Campbell, ... The lancet oncology 16 (6), 676-685, 2015 | 259 | 2015 |
| Advanced hepatocellular carcinoma: early evaluation of response to bevacizumab therapy at dynamic contrast-enhanced US with quantification—preliminary results N Lassau, S Koscielny, L Chami, M Chebil, B Benatsou, A Roche, ... Radiology 258 (1), 291-300, 2011 | 253 | 2011 |
| Characteristic repartition of monocyte subsets as a diagnostic signature of chronic myelomonocytic leukemia D Selimoglu-Buet, O Wagner-Ballon, V Saada, V Bardet, R Itzykson, ... Blood, The Journal of the American Society of Hematology 125 (23), 3618-3626, 2015 | 249 | 2015 |
| The JAK2 617V>F mutation triggers erythropoietin hypersensitivity and terminal erythroid amplification in primary cells from patients with polycythemia vera S Dupont, A Massé, C James, I Teyssandier, Y Lécluse, F Larbret, V Ugo, ... Blood, The Journal of the American Society of Hematology 110 (3), 1013-1021, 2007 | 231 | 2007 |
| Mutation allele burden remains unchanged in chronic myelomonocytic leukaemia responding to hypomethylating agents J Merlevede, N Droin, T Qin, K Meldi, K Yoshida, M Morabito, E Chautard, ... Nature communications 7 (1), 10767, 2016 | 225 | 2016 |
| Metastatic renal cell carcinoma treated with sunitinib: early evaluation of treatment response using dynamic contrast-enhanced ultrasonography N Lassau, S Koscielny, L Albiges, L Chami, B Benatsou, M Chebil, ... Clinical Cancer Research 16 (4), 1216-1225, 2010 | 225 | 2010 |
| The poor responsiveness of infiltrating lobular breast carcinomas to neoadjuvant chemotherapy can be explained by their biological profile MC Mathieu, R Rouzier, A Llombart-Cussac, L Sideris, S Koscielny, ... European journal of cancer 40 (3), 342-351, 2004 | 221 | 2004 |
| Rituximab and dose-dense chemotherapy for adults with Burkitt's lymphoma: a randomised, controlled, open-label, phase 3 trial V Ribrag, S Koscielny, J Bosq, T Leguay, O Casasnovas, LM Fornecker, ... The Lancet 387 (10036), 2402-2411, 2016 | 203 | 2016 |
| Burkitt lymphoma in adults: a prospective study of 72 patients treated with an adapted pediatric LMB protocol M Divine, P Casassus, S Koscielny, J Bosq, C Sebban, C Le Maignan, ... Annals of oncology 16 (12), 1928-1935, 2005 | 183 | 2005 |
| Tumor growth rate is an early indicator of antitumor drug activity in phase I clinical trials C Ferté, M Fernandez, A Hollebecque, S Koscielny, A Levy, C Massard, ... Clinical Cancer Research 20 (1), 246-252, 2014 | 178 | 2014 |
| Growth rate, kinetics of tumor cell proliferation and long‐term outcome in human breast cancer M Tubiana, MH Pejovic, S Koscielny, N Chavaudra, E Malaise International journal of cancer 44 (1), 17-22, 1989 | 171 | 1989 |
| Full dose reirradiation combined with chemotherapy after salvage surgery in head and neck carcinoma R De Crevoisier, C Domenge, P Wibault, S Koscielny, A Lusinchi, F Janot, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2001 | 162 | 2001 |
| Serum 2-Hydroxyglutarate Production in IDH1- and IDH2-Mutated De Novo Acute Myeloid Leukemia: A Study by the Acute Leukemia French Association Group M Janin, E Mylonas, V Saada, JB Micol, A Renneville, C Quivoron, ... Journal of Clinical Oncology 32 (4), 297-305, 2014 | 159 | 2014 |
| Validation of dynamic contrast-enhanced ultrasound in predicting outcomes of antiangiogenic therapy for solid tumors: the French multicenter support for innovative and … N Lassau, J Bonastre, M Kind, V Vilgrain, J Lacroix, M Cuinet, S Taieb, ... Investigative radiology 49 (12), 794-800, 2014 | 153 | 2014 |
